Promoting the use of point of care testing in non-communicable disease screening among university students

Maniki, Pauline Tendai; Khan, Razeeya; Orchard, Ané; Rapper, Stephanie de; Padayachee, Neelaveni

doi:10.1016/j.ijans.2022.100446

Cited by 2 publications

(1 citation statement)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…At the same time, the increase in morbidity and mortality rates in recent times due to alarming levels of NCDs such as diabetes, stroke, cancer, type-2 diabetes, and Alzheimer's disease has exponentially increased the demand for POCT applications for diagnosing these diseases [ 26 ]. The diagnosis of NCDs, which previously heavily relied upon laborious biochemical measurements, is now being replaced by simpler detection tools without compromising on detection sensitivity and specificity [ 27 ].…”

Section: Point-of-care Testingmentioning

confidence: 99%

Lateral flow assay: a promising rapid point-of-care testing tool for infections and non-communicable diseases

Vealan,

Joseph,

Alimat

et al. 2023

Asian Biomedicine

View full text Add to dashboard Cite

The point-of-care testing (POCT) approach has established itself as having remarkable importance in diagnosing various infectious and non-communicable diseases (NCDs). The POCT approach has succeeded in meeting the current demand for having diagnostic strategies that can provide fast, sensitive, and highly accurate test results without involving complicated procedures. This has been accomplished by introducing rapid bioanalytical tools or biosensors such as lateral flow assays (LFAs). The production cost of these tools is very low, allowing developing countries with limited resources to utilize them or produce them on their own. Thus, their use has grown in various fields in recent years. More importantly, LFAs have created the possibility for a new era of incorporating nanotechnology in disease diagnosis and have already attained significant commercial success worldwide, making POCT an essential approach not just for now but also for the future. In this review, we have provided an overview of POCT and its evolution into the most promising rapid diagnostic approach. We also elaborate on LFAs with a special focus on nucleic acid LFAs.

show abstract

Section: Point-of-care Testingmentioning

confidence: 99%